Innovative Medicines Initiative logo

Innovative Medicines Initiative

Europe, Brussels Hoofdstedelijk Gewest, Belgium, Berchem

Description

Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development

Investor Profile

Innovative Medicines Initiative has made 2 investments, with 0 in the past 12 months and 100% as lead.

Stage Focus

  • Grant (100%)

Country Focus

  • United Kingdom (50%)
  • Germany (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Pharmaceutical
  • Consulting
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

What are some of recent deals done by Innovative Medicines Initiative?

Exvastat

Cambridge, Cambridgeshire, United Kingdom

Exvastat is an innovative, preclinical-stage pharmaceutical company.

BiotechnologyHealth CareLife ScienceMedicalPharmaceutical
GrantMay 15, 2020
Amount Raised: $3,895,775
MetaHeps

Martinsried, Bayern, Germany

MetaHeps provides solutions for drug-induced liver injury (DILI) in clinical drug-development and postmarketing.

BiotechnologyConsultingHealth Care
GrantJan 1, 2019